Revenue Upgrade – Talk Bio

Actionable Insights Powered by AI

Astellas Pharma Revises Financial Forecasts for FY2025

2 days ago talkbio0Tagged Astellas, Drug Industry, Financial Forecast Revision, FY2025, operating profit, Optimization, Pipeline Progress, Revenue Upgrade, SG&A, strategic brands

Astellas; Financial Forecast Revision; FY2025; Revenue Upgrade; Operating Profit; Pharmaceutical Industry; Strategic Brands; Pipeline Progress; SG&A Optimization